z-logo
open-access-imgOpen Access
Screening for Cervical Cancer
Author(s) -
Patiyus Agustiansyah,
Rizal Sanif,
Siti Nurmaini,
Irfannuddin Irfannuddin,
Legiran
Publication year - 2021
Publication title -
bioscientia medicina journal of biomedicine and translational research
Language(s) - English
Resource type - Journals
ISSN - 2598-0580
DOI - 10.32539/bsm.v5i10.329
Subject(s) - medicine , disease , asymptomatic , cervical cancer , cancer , cancer screening , population , screening test , stage (stratigraphy) , public health , intervention (counseling) , intensive care medicine , pediatrics , pathology , psychiatry , environmental health , paleontology , biology
Screening is a public health intervention administered to a target population without symptoms. Screening is not performed to diagnose a disease, but to identify individuals with a higher likelihood of developing the disease itself or a precursor to the disease. Not all diseases are suitable for screening programs. The following criteria help determine whether a disease is suitable for a screening program: (1) The disease is bound to have serious consequences. (2) The disease must have a detectable preclinical and asymptomatic stage. (3) Treatment at the preclinical stage should influence the long-term course and prognosis of the disease being screened. (4) Care must be available and accessible to those who have a positive screening test. History, screening tests and treatment options for cervical pre-cancer meet these criteria.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom